Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Journal of Biomechanics|October 18, 2017
A comprehensive assessment of the musculoskeletal system: The CAMS-Knee data setWilliam R Taylor, Pascal Schütz, Georg Bergmann, et al.Journal of Cosmetic Dermatology|March 27, 2022
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trialSeyyedeh Maryam Afshani, Aniseh Samadi, Azin Ayatollahi, et al.The American Journal of Cardiology|May 14, 2020
Comparison of Outcomes of Alcohol Septal Ablation or Septal Myectomy for Hypertrophic Cardiomyopathy in Patients ≤65 Years Versus >65 YearsAlejandro Lemor, Pedro A Villablanca, Seyed Hamed Hosseini Dehkordi, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 30, 2022
Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase III, noninferiority clinical trialSeyyedeh Maryam Afshani, Reihaneh Mirhassani, Hamed Hosseini, et al.International Immunopharmacology|May 18, 2024
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-upMohammadreza Salehi, Ilad Alavi Darazam, Alireza Nematollahi, et al.Journal of Biomechanics|July 8, 2022
European Society of Biomechanics S.M. Perren Award 2022: Standardized tibio-femoral implant loads and kinematicsMichael J Dreyer, Adam Trepczynski, Seyyed Hamed Hosseini Nasab, et al.BMJ Open|April 9, 2022
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adultsMinoo Mohraz, Mohammadreza Salehi, Payam Tabarsi, et al.PLOS Global Public Health|November 24, 2025
The SnaFab versus the Razi antivenom for treatment of snakebite envenomation: A randomized, double-blind (investigator and victims), active controlled, non-inferiority clinical trialSeyed Reza Mousavi, Alihasan Rahmani, Maryam Amini Pouya, et al.BMJ (Clinical Research Ed.)|September 21, 2023
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trialMinoo Mohraz, Katayoun Vahdat, Seyyed-Hadi Ghamari, et al.Nature Biomedical Engineering|May 9, 2022
An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluidFarshad Tehrani, Hazhir Teymourian, Brian Wuerstle, et al.Pageof 13